生命科学资讯

Morgan Stanley Initiates Coverage on Agilent Technologies (A) wi - GuruFocus

Pfizer culls ulcerative colitis candidate; Tiziana to try spinning out IL-6 drug

TXG: Morgan Stanley Downgrades 10x Genomics, Raises Price Target | TXG Stock News - GuruFocus

TXG: Morgan Stanley Downgrades 10x Genomics, Raises Price Target - GuruFocus

Janux sinks on ‘overreaction’ to prostate cancer data; RFK Jr. replaces ACIP chair

Vandria’s phase I data offer new mode of action in Alzheimer’s

As approval date looms, Cytokinetics gears up for David-and-Goliath battle with Bristol Myers

Low-dose mixtures of dietary nutrients ameliorate behavioral deficits in multiple mouse models of autism

RIN1 regulates developmental and pain-related plasticity in spinal synapses via NMDA receptor subunit trafficking

Polar cell membrane nanotubes containing microtubules and acidic vesicles render Drosophila eggs fertile

Trends and Tools Transforming Drug Discovery: Five Takeaways from Discover Glo 2025

Helicore stops work on clinical GIP antagonist after Phase 1 results

Agilent Technologies price driven lower by pivotal resistance - Forecast today - 02-12-2025 - Economies.com

Targeted Sequencing Industry Intelligence 2020-2030 - GlobeNewswire

Targeted Sequencing Industry Intelligence 2020-2030 Featuring Profiles of MGI Tech, GENEWIZ, Agilent Technologies and Other Leading Companies - Yahoo Finance

Trial Library raises $10M to sell clinical trial matching to insurers

HIV remission after heterozygous CCR5Δ32 stem cell transplant

Novo, J&J Alzheimer’s clinical flops teach bruised field valuable lessons

Chinese researchers patent new URAT1 inhibitors

Abbisko Therapeutics divulges new SMARCA2 inhibitors